Implementation of a high-dose-rate brachytherapy program for carcinoma of the cervix in Senegal: a pragmatic model for the developing world

JP Einck, A Hudson, AC Shulman, CM Yashar… - International Journal of …, 2014 - Elsevier
West Africa has one of the highest incidence rates of carcinoma of the cervix in the world.
The vast majority of women do not have access to screening or disease treatment, leading to …

[PDF][PDF] Concomitant cisplatin plus radiotherapy and high–dose-rate brachytherapy versus radiotherapy alone for stage IIIB epidermoid cervical cancer: a randomized …

AC Zuliani, SC Barros Esteves… - Journal of clinical …, 2014 - medspecpublishing.co.za
Purpose The benefits of chemoradiotherapy (CRT) for cervical cancer compared with
radiation (RT) alone seem to diminish in later-stage disease. However, these modalities …

Point-A vs. volume-based brachytherapy for the treatment of cervix cancer: A meta-analysis

V Hande, S Chopra, B Kalra, M Abdel-Wahab… - Radiotherapy and …, 2022 - Elsevier
Abstract Background & Purpose To report disease-free survival (DFS) for volume-based and
point-A based brachytherapy (BT) in locally advanced cervical cancer. Materials & Methods …

奈达铂同步放化疗与顺铂+ 5-氟尿嘧啶同步放化疗治疗中晚期宫颈癌的疗效和安全性比较

高平, 关小倩, 高亚杰 - 中国妇幼保健, 2013 - cqvip.com
目的: 探讨中晚期宫颈癌患者在放疗同时进行奈达铂同步放化疗与顺铂+ 5-
氟尿嘧啶同步放化疗两种治疗方案的疗效, 不良反应. 方法: 选择中晚期宫颈癌患者86 例 …

Long-term follow-up results of a multi-institutional phase 2 study of concurrent chemoradiation therapy for locally advanced cervical cancer in east and southeast Asia

S Kato, T Ohno, K Thephamongkhol… - International Journal of …, 2013 - Elsevier
Purpose To report the long-term survival and toxicity of a multi-institutional phase 2 study of
concurrent chemoradiation therapy (CCRT) for locally advanced cervical cancer in east and …

中晚期宫颈癌患者奈达铂与顺铂联合5-氟尿嘧啶方案同步放化疗疗效及安全性对比分析

赵晶清, 赵彩虹, 赵妤, 韩江琼, 邹宓 - 中国全科医学, 2013 - cqvip.com
目的探讨奈达铂与顺铂联合5-氟尿嘧啶方案同步放化疗治疗中晚期宫颈癌患者的疗效和安全性.
方法选择我院于2010 年7 月-2012 年3 月确诊的中晚期宫颈癌患者78 例 …

[HTML][HTML] A comparative analysis of two different dose fractionation regimens of high dose rate intracavitary brachytherapy in treatment of carcinoma of uterine cervix: a …

BS Rao, P Das, BV Subramanian, A Jena… - Journal of Clinical …, 2017 - ncbi.nlm.nih.gov
Aim To assess the feasibility, tolerability of HDR intracavitary brachytherapy schedule of 8
Gy per fraction per week for 3 fractions over 6Gy per fraction per week for 4 fractions with or …

The Prevalence and Factors Related to Late-Stage Among Cervical Cancer Patients in Southeast Asian countries: A Systematic Review and Meta-Analysis

TQC Vu, TG Truong, QD Tran, MT Bui - Indian Journal of Gynecologic …, 2024 - Springer
Background Cervical cancer is a significant public health problem in Southeast Asia, where
it ranks seventh in incidence and sixth in mortality in 2020. However, there is a lack of …

[HTML][HTML] A comparative study between two different dose fractionation schedules of cobalt-60-based HDR intracavitary brachytherapy in carcinoma cervix stages IIB …

V Gagrani, J Kabara, A Shukla… - Journal of Cancer …, 2024 - journals.lww.com
Objective: The aim of this study was to study the acute treatment-related gastrointestinal (GI)
and genitourinary (GU) toxicities between two HDR brachytherapy regimens. Material and …

中晚期宫颈鳞癌放化疗后复发未控的相关因素及疗效分析

夏蕾, 罗宝华 - 安徽医药, 2015 - cqvip.com
目的探讨中晚期宫颈鳞癌放化疗后复发未控的相关因素, 且分析其临床疗效. 方法选择2012 年1
月—2014 年12 月该院收治的190 例中晚期宫颈鳞癌患者作为研究对象, 按照数字列表法随机分 …